Ryerson CFO sells 4,972 shares at $30 each

Ryerson Holding Corp's Executive Vice President and CFO, James J. Claussen, reported selling 4,972 shares of common stock on February 3, 2026 at $30 per share.

Accepted by SEC EDGAR 02/04/2026 - 04:26 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Ryerson Holding Corp's Executive Vice President and CFO, James J. Claussen, reported selling 4,972 shares of common stock on February 3, 2026 at $30 per share.

After this transaction, he beneficially owned 74,284.3365 shares. The sale was made under a pre-established Rule 10b5-1 trading plan adopted on October 30, 2025.

Insider Trade Summary

Net Seller: 4,972 shares

Net Sell 1 txn

Insider Claussen James J

Role Executive Vice President & CFO

Sold 4,972 shs ($149K)

Share of Position Sold 6.3%

Type	Security	Shares	Price	Value
Sale	Common Stock (par value $0.01 per share)	4,972	$30.00	$149K

Holdings After Transaction: Common Stock (par value $0.01 per share) — 74,284.3365 shares (Direct)

Holdings Before and After: Common Stock (par value $0.01 per share), 79,256.3365 to 74,284.3365 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ryerson (RYI) report for James J. Claussen?

Ryerson reported that Executive Vice President and CFO James J. Claussen sold 4,972 shares of common stock on February 3, 2026 at $30 per share. The filing shows this as an open market sale coded as transaction type S.

How many Ryerson (RYI) shares does the CFO hold after the reported sale?

After the sale, Executive Vice President and CFO James J. Claussen beneficially owned 74,284.3365 shares of Ryerson common stock. This figure reflects his holdings immediately following the February 3, 2026 transaction reported in the Form 4 filing.

At what price did the Ryerson (RYI) CFO sell his shares on February 3, 2026?

The Form 4 shows that 4,972 shares of Ryerson common stock were sold at a price of $30 per share on February 3, 2026. This price is reported as the transaction price for the non-derivative stock sale.

Was the Ryerson (RYI) CFO’s stock sale made under a Rule 10b5-1 trading plan?

Yes. The footnote explains that the sale was effected under a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025. Such plans pre-schedule trades according to predetermined instructions.

What role does the insider in this Ryerson (RYI) Form 4 hold at the company?

The reporting person on the Form 4, James J. Claussen, is identified as an Executive Vice President & CFO of Ryerson Holding Corp. The filing does not mark him as a director or a 10% beneficial owner.

Did the Ryerson (RYI) Form 4 report any derivative securities transactions?

No derivative securities transactions are reported. The section for derivative securities lists no acquired or disposed instruments. The only reported activity is the non-derivative common stock sale of 4,972 shares at $30 per share on February 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Claussen James J

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (par value $0.01 per share)	02/03/2026		S(1)		4,972	D	$30	74,284.3365	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.

	/s/ Camilla Rykke Merrick, attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.